ReP USP - Resultado da busca

Artigo de periodico
DTI-derived parameters differ between moderate and severe traumatic brain injury and its association with psychiatric scores (2022)
Zaninotto, Ana Luiza; Grassi, Daphine Centola; Duarte, Dante; Rodrigues, Priscila Aparecida; Cardoso, Ellison; Feltrin, Fabricio Stewan; Guirado, Vinicius Monteiro de Paula; Macruz, Fabiola Bezerra de Carvalho; Otaduy, Maria Concepcion Garcia; Leite, Claudia da Costa ; Paiva, Wellingson Silva; Andrade, Celi Santos
Source: Neurological sciences. Unidade: FM
Subjects: IMAGEM DIGITAL, LESÃO AXONAL DIFUSA, SINAIS E SINTOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANINOTTO, Ana Luiza et al. DTI-derived parameters differ between moderate and severe traumatic brain injury and its association with psychiatric scores. Neurological sciences, v. 43, n. 2, p. 1343-1350, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10072-021-05455-0. Acesso em: 13 nov. 2024.
APA
Zaninotto, A. L., Grassi, D. C., Duarte, D., Rodrigues, P. A., Cardoso, E., Feltrin, F. S., et al. (2022). DTI-derived parameters differ between moderate and severe traumatic brain injury and its association with psychiatric scores. Neurological sciences, 43( 2), 1343-1350. doi:10.1007/s10072-021-05455-0
NLM
Zaninotto AL, Grassi DC, Duarte D, Rodrigues PA, Cardoso E, Feltrin FS, Guirado VM de P, Macruz FB de C, Otaduy MCG, Leite C da C, Paiva WS, Andrade CS. DTI-derived parameters differ between moderate and severe traumatic brain injury and its association with psychiatric scores [Internet]. Neurological sciences. 2022 ; 43( 2): 1343-1350.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10072-021-05455-0
Vancouver
Zaninotto AL, Grassi DC, Duarte D, Rodrigues PA, Cardoso E, Feltrin FS, Guirado VM de P, Macruz FB de C, Otaduy MCG, Leite C da C, Paiva WS, Andrade CS. DTI-derived parameters differ between moderate and severe traumatic brain injury and its association with psychiatric scores [Internet]. Neurological sciences. 2022 ; 43( 2): 1343-1350.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10072-021-05455-0
Artigo de periodico
Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients (2015)
Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Chung, Janete; Freitas, Vanessa Morais ; Demachki, Samia; Assumpção, Paulo Pimentel; Chammas, Roger; Burbano, Rommel Rodríguez; Smith, Marília Cardoso
Source: Clinical and Experimental Medicine. Unidades: FM, ICB
Subjects: NEOPLASIAS DO SISTEMA DIGESTÓRIO, METÁSTASE NEOPLÁSICA (FISIOPATOLOGIA), EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clinical and Experimental Medicine, v. 15, n. 3, p. 415-420, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10238-014-0299-0. Acesso em: 13 nov. 2024.
APA
Leal, M. F., Calcagno, D. Q., Chung, J., Freitas, V. M., Demachki, S., Assumpção, P. P., et al. (2015). Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clinical and Experimental Medicine, 15( 3), 415-420. doi:10.1007/s10238-014-0299-0
NLM
Leal MF, Calcagno DQ, Chung J, Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients [Internet]. Clinical and Experimental Medicine. 2015 ; 15( 3): 415-420.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10238-014-0299-0
Vancouver
Leal MF, Calcagno DQ, Chung J, Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients [Internet]. Clinical and Experimental Medicine. 2015 ; 15( 3): 415-420.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10238-014-0299-0
Artigo de periodico
Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm: A new view on so-called “hepatoid adenocarcinoma of the gallbladder” (2014)
Dettoni, J. B.; Andrauss, W.; Theise, N. D.; Rocha, M. S.; Mello, E. S.; Rocha, C. H. L.; Pfiffer, T. E. F.; Alves, V. A. F.
Source: Pathologica. Unidade: FM
Subjects: HEPATOPATIAS, NEOPLASIAS HEPÁTICAS, VESÍCULA BILIAR (FISIOPATOLOGIA), CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DETTONI, J. B. et al. Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm: A new view on so-called “hepatoid adenocarcinoma of the gallbladder”. Pathologica, v. 106, n. 1, p. 7-13, 2014Tradução . . Disponível em: http://www.pacinieditore.it/pathologica/issues/2014/PATHOLOGICA_1_14.pdf. Acesso em: 13 nov. 2024.
APA
Dettoni, J. B., Andrauss, W., Theise, N. D., Rocha, M. S., Mello, E. S., Rocha, C. H. L., et al. (2014). Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm: A new view on so-called “hepatoid adenocarcinoma of the gallbladder”. Pathologica, 106( 1), 7-13. Recuperado de http://www.pacinieditore.it/pathologica/issues/2014/PATHOLOGICA_1_14.pdf
NLM
Dettoni JB, Andrauss W, Theise ND, Rocha MS, Mello ES, Rocha CHL, Pfiffer TEF, Alves VAF. Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm: A new view on so-called “hepatoid adenocarcinoma of the gallbladder” [Internet]. Pathologica. 2014 ; 106( 1): 7-13.[citado 2024 nov. 13 ] Available from: http://www.pacinieditore.it/pathologica/issues/2014/PATHOLOGICA_1_14.pdf
Vancouver
Dettoni JB, Andrauss W, Theise ND, Rocha MS, Mello ES, Rocha CHL, Pfiffer TEF, Alves VAF. Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm: A new view on so-called “hepatoid adenocarcinoma of the gallbladder” [Internet]. Pathologica. 2014 ; 106( 1): 7-13.[citado 2024 nov. 13 ] Available from: http://www.pacinieditore.it/pathologica/issues/2014/PATHOLOGICA_1_14.pdf
Artigo de periodico
Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging (2014)
Perez, R. O.; Habr-Gama, A.; São Julião, G. P.; Lynn, P. B.; Sabbagh, C.; Proscurshim, I.; Campos, F. G.; Gama-Rodrigues, J.; Nahas, S. C.; Buchpiguel, C. A.
Source: Techniques in Coloproctology. Unidade: FM
Subjects: NEOPLASIAS RETAIS (TERAPIA), CO-TERAPIA, DIAGNÓSTICO POR IMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, R. O. et al. Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging. Techniques in Coloproctology, v. 18, n. 8, p. 699-708, 2014Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs10151-013-1113-9. Acesso em: 13 nov. 2024.
APA
Perez, R. O., Habr-Gama, A., São Julião, G. P., Lynn, P. B., Sabbagh, C., Proscurshim, I., et al. (2014). Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging. Techniques in Coloproctology, 18( 8), 699-708. doi:10.1007/s10151-013-1113-9
NLM
Perez RO, Habr-Gama A, São Julião GP, Lynn PB, Sabbagh C, Proscurshim I, Campos FG, Gama-Rodrigues J, Nahas SC, Buchpiguel CA. Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging [Internet]. Techniques in Coloproctology. 2014 ; 18( 8): 699-708.[citado 2024 nov. 13 ] Available from: http://link.springer.com/article/10.1007%2Fs10151-013-1113-9
Vancouver
Perez RO, Habr-Gama A, São Julião GP, Lynn PB, Sabbagh C, Proscurshim I, Campos FG, Gama-Rodrigues J, Nahas SC, Buchpiguel CA. Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging [Internet]. Techniques in Coloproctology. 2014 ; 18( 8): 699-708.[citado 2024 nov. 13 ] Available from: http://link.springer.com/article/10.1007%2Fs10151-013-1113-9
Trabalho de evento-resumo periodico
Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients (2014)
Morais, J.; Martin, P.; Velosa, A. P. P.; Andrade, P. C.; Cruz, I. B.; Miracca, E. C.; Barrence, F. A. C.; Carrasco, S.; Goldeinstein-Schainberg, C.; Nagai, M. A.; Parra, E. R.; Capelozzi, V. L.; Teodoro, W. R.
Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidades: FM, ICB
Subjects: IMUNOLOGIA, EXPRESÃO GÊNICA, COLÁGENO, SISTÊMICO ESCLERODERMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, J. et al. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8201. Acesso em: 13 nov. 2024. , 2014
APA
Morais, J., Martin, P., Velosa, A. P. P., Andrade, P. C., Cruz, I. B., Miracca, E. C., et al. (2014). Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8201
NLM
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 nov. 13 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Vancouver
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 nov. 13 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Trabalho de evento-resumo periodico
Polymorphisms of estrogen receptor-α gene in Brazilian women with high breast density after menopause (2013)
Souza, M. A.; Fonseca, A. M.; Bagnoli, V. R.; De Barros, N.; Mendonça, E. N.; Hortense, V. H.; Soares Jr., J. M.; Baracat, E. C.
Source: Giornale Italiano di Obstetricia e Ginecologia. Conference titles: World Congress on Human reproduction. Unidade: FM
Subjects: MENOPAUSA, BRASILEIROS, ESTROGÉNOS, MAMA (FISIOPATOLOGIA), POLIMORFISMO, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, M. A. et al. Polymorphisms of estrogen receptor-α gene in Brazilian women with high breast density after menopause. Giornale Italiano di Obstetricia e Ginecologia. Torino: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.giog.it/common/php/portiere.php?ID=a87b8c19ec6c9f6b9735557c79944910. Acesso em: 13 nov. 2024. , 2013
APA
Souza, M. A., Fonseca, A. M., Bagnoli, V. R., De Barros, N., Mendonça, E. N., Hortense, V. H., et al. (2013). Polymorphisms of estrogen receptor-α gene in Brazilian women with high breast density after menopause. Giornale Italiano di Obstetricia e Ginecologia. Torino: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.giog.it/common/php/portiere.php?ID=a87b8c19ec6c9f6b9735557c79944910
NLM
Souza MA, Fonseca AM, Bagnoli VR, De Barros N, Mendonça EN, Hortense VH, Soares Jr. JM, Baracat EC. Polymorphisms of estrogen receptor-α gene in Brazilian women with high breast density after menopause [Internet]. Giornale Italiano di Obstetricia e Ginecologia. 2013 ; 35( 1): 343-348.[citado 2024 nov. 13 ] Available from: http://www.giog.it/common/php/portiere.php?ID=a87b8c19ec6c9f6b9735557c79944910
Vancouver
Souza MA, Fonseca AM, Bagnoli VR, De Barros N, Mendonça EN, Hortense VH, Soares Jr. JM, Baracat EC. Polymorphisms of estrogen receptor-α gene in Brazilian women with high breast density after menopause [Internet]. Giornale Italiano di Obstetricia e Ginecologia. 2013 ; 35( 1): 343-348.[citado 2024 nov. 13 ] Available from: http://www.giog.it/common/php/portiere.php?ID=a87b8c19ec6c9f6b9735557c79944910
Artigo de periodico
Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors (2013)
Ferrarotto, Renata; Testa, Laura; Riechelmann, Rachel P.; Sahade, Marina; Siqueira, Luiz T.; Costa, Frederico P.; Hoff, Paulo M.
Source: Rare tumors. Unidade: FM
Subjects: NEOPLASIA ENDÓCRINA MÚLTIPLA (TERAPIA), ESTUDOS RETROSPECTIVOS, METÁSTASE NEOPLÁSICA, BIÓPSIA, PROLIFERAÇÃO CELULAR, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAROTTO, Renata et al. Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors. Rare tumors, v. 5, n. 3, p. 121-125, 2013Tradução . . Disponível em: https://doi.org/10.4081/rt.2013.e35. Acesso em: 13 nov. 2024.
APA
Ferrarotto, R., Testa, L., Riechelmann, R. P., Sahade, M., Siqueira, L. T., Costa, F. P., & Hoff, P. M. (2013). Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors. Rare tumors, 5( 3), 121-125. doi:10.4081/rt.2013.e35
NLM
Ferrarotto R, Testa L, Riechelmann RP, Sahade M, Siqueira LT, Costa FP, Hoff PM. Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors [Internet]. Rare tumors. 2013 ; 5( 3): 121-125.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4081/rt.2013.e35
Vancouver
Ferrarotto R, Testa L, Riechelmann RP, Sahade M, Siqueira LT, Costa FP, Hoff PM. Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors [Internet]. Rare tumors. 2013 ; 5( 3): 121-125.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4081/rt.2013.e35
Artigo de periodico
Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas (2013)
Munhoz, Rodrigo Ramella; Rego, Juliana Florinda de Mendonca; Ferrari, Anezka Rubim de Celis; Braghiroli, Maria Ignez; Bariani, Giovanni Mendonca; Hoff, Paulo Marcelo; Costa, Frederico Perego; Pfiffer, Tulio Eduardo Flesch; Riechelmann, Rachel
Source: Rare tumors. Unidade: FM
Subjects: NEOPLASIA ENDÓCRINA MÚLTIPLA, ESTUDOS RETROSPECTIVOS, METÁSTASE NEOPLÁSICA (DIAGNÓSTICO), PROLIFERAÇÃO CELULAR, ANTINEOPLÁSICOS (USO TERAPÊUTICO), CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNHOZ, Rodrigo Ramella et al. Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas. Rare tumors, v. 5, n. 3, p. 135-139, 2013Tradução . . Disponível em: https://doi.org/10.4081/rt.2013.e39. Acesso em: 13 nov. 2024.
APA
Munhoz, R. R., Rego, J. F. de M., Ferrari, A. R. de C., Braghiroli, M. I., Bariani, G. M., Hoff, P. M., et al. (2013). Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas. Rare tumors, 5( 3), 135-139. doi:10.4081/rt.2013.e39
NLM
Munhoz RR, Rego JF de M, Ferrari AR de C, Braghiroli MI, Bariani GM, Hoff PM, Costa FP, Pfiffer TEF, Riechelmann R. Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas [Internet]. Rare tumors. 2013 ; 5( 3): 135-139.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4081/rt.2013.e39
Vancouver
Munhoz RR, Rego JF de M, Ferrari AR de C, Braghiroli MI, Bariani GM, Hoff PM, Costa FP, Pfiffer TEF, Riechelmann R. Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas [Internet]. Rare tumors. 2013 ; 5( 3): 135-139.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4081/rt.2013.e39
Artigo de periodico
Increased variability of motor cortical excitability to transcranial magnetic stimulation in migraine: a new clue to an old enigma (2012)
Conforto, Adriana B.; Moraes, Mariana S.; Amaro Jr., Edson; Young, William B.; Lois, Lais A.; Gonçalves, André L.; Peres, Mario F. P.
Source: The Journal of Headache and Pain. Unidade: FM
Subjects: ENXAQUECA, ESTIMULAÇÃO CEREBRAL, CÓRTEX CEREBRAL, NEUROFISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONFORTO, Adriana B. et al. Increased variability of motor cortical excitability to transcranial magnetic stimulation in migraine: a new clue to an old enigma. The Journal of Headache and Pain, v. 13, n. 1, p. 29-37, 2012Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs10194-011-0379-4. Acesso em: 13 nov. 2024.
APA
Conforto, A. B., Moraes, M. S., Amaro Jr., E., Young, W. B., Lois, L. A., Gonçalves, A. L., & Peres, M. F. P. (2012). Increased variability of motor cortical excitability to transcranial magnetic stimulation in migraine: a new clue to an old enigma. The Journal of Headache and Pain, 13( 1), 29-37. doi:10.1007%2Fs10194-011-0379-4
NLM
Conforto AB, Moraes MS, Amaro Jr. E, Young WB, Lois LA, Gonçalves AL, Peres MFP. Increased variability of motor cortical excitability to transcranial magnetic stimulation in migraine: a new clue to an old enigma [Internet]. The Journal of Headache and Pain. 2012 ; 13( 1): 29-37.[citado 2024 nov. 13 ] Available from: http://link.springer.com/article/10.1007%2Fs10194-011-0379-4
Vancouver
Conforto AB, Moraes MS, Amaro Jr. E, Young WB, Lois LA, Gonçalves AL, Peres MFP. Increased variability of motor cortical excitability to transcranial magnetic stimulation in migraine: a new clue to an old enigma [Internet]. The Journal of Headache and Pain. 2012 ; 13( 1): 29-37.[citado 2024 nov. 13 ] Available from: http://link.springer.com/article/10.1007%2Fs10194-011-0379-4
Artigo de periodico
Rare tumors research in emerging countries (2010)
Mano, Max S.; Arai, Roberto J.; Hoff, Paulo M. G.
Source: Rare tumors. Unidade: FM
Subjects: NEOPLASIAS (MORTALIDADE), TRIAGEM, PAÍSES EM DESENVOLVIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANO, Max S. e ARAI, Roberto J. e HOFF, Paulo M. G. Rare tumors research in emerging countries. Rare tumors, v. 2, n. 3, p. 142-143, 2010Tradução . . Disponível em: https://doi.org/10.4081/rt.2010.e49. Acesso em: 13 nov. 2024.
APA
Mano, M. S., Arai, R. J., & Hoff, P. M. G. (2010). Rare tumors research in emerging countries. Rare tumors, 2( 3), 142-143. doi:10.4081/rt.2010.e49
NLM
Mano MS, Arai RJ, Hoff PMG. Rare tumors research in emerging countries [Internet]. Rare tumors. 2010 ; 2( 3): 142-143.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4081/rt.2010.e49
Vancouver
Mano MS, Arai RJ, Hoff PMG. Rare tumors research in emerging countries [Internet]. Rare tumors. 2010 ; 2( 3): 142-143.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4081/rt.2010.e49
Trabalho de evento-resumo
Posttranslational proteomic approach to study N-glycan profiling and protein phosphorylation of murine melanoma cell lines by combination of MALDI-TOF/TOF and ESI-Q-TOF mass spectroscopy (2010)
Rosa, José César; Melo, Talita Diniz; Zimmermann, Lara; Chammas, Roger; Laure, Hélen Julie
Source: Proceedings. Conference titles: Annual Mass Spec Europe. Unidades: FMRP, FM
Subjects: MELANOMA, ESPECTROSCOPIA DE MASSA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSA, José César et al. Posttranslational proteomic approach to study N-glycan profiling and protein phosphorylation of murine melanoma cell lines by combination of MALDI-TOF/TOF and ESI-Q-TOF mass spectroscopy. 2010, Anais.. Florence: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 13 nov. 2024.
APA
Rosa, J. C., Melo, T. D., Zimmermann, L., Chammas, R., & Laure, H. J. (2010). Posttranslational proteomic approach to study N-glycan profiling and protein phosphorylation of murine melanoma cell lines by combination of MALDI-TOF/TOF and ESI-Q-TOF mass spectroscopy. In Proceedings. Florence: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Rosa JC, Melo TD, Zimmermann L, Chammas R, Laure HJ. Posttranslational proteomic approach to study N-glycan profiling and protein phosphorylation of murine melanoma cell lines by combination of MALDI-TOF/TOF and ESI-Q-TOF mass spectroscopy. Proceedings. 2010 ;[citado 2024 nov. 13 ]
Vancouver
Rosa JC, Melo TD, Zimmermann L, Chammas R, Laure HJ. Posttranslational proteomic approach to study N-glycan profiling and protein phosphorylation of murine melanoma cell lines by combination of MALDI-TOF/TOF and ESI-Q-TOF mass spectroscopy. Proceedings. 2010 ;[citado 2024 nov. 13 ]
Artigo de periodico
Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature (2010)
Ferrarotto, Renata; Schetino, Guilherme; Freitas, Daniela; Capelozzi, Vera; Hoff, Paulo M.
Source: Oncology Reviews. Unidade: FM
Subjects: DOENÇAS PULMONARES INTERSTICIAIS, DOENÇA CRÔNICA, NEOPLASIA ENDÓCRINA MÚLTIPLA, ESTADIAMENTO DE NEOPLASIAS, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAROTTO, Renata et al. Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature. Oncology Reviews, v. 4, n. 1, p. 101-106, 2010Tradução . . Disponível em: https://doi.org/10.4081/53. Acesso em: 13 nov. 2024.
APA
Ferrarotto, R., Schetino, G., Freitas, D., Capelozzi, V., & Hoff, P. M. (2010). Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature. Oncology Reviews, 4( 1), 101-106. doi:10.4081/53
NLM
Ferrarotto R, Schetino G, Freitas D, Capelozzi V, Hoff PM. Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature [Internet]. Oncology Reviews. 2010 ; 4( 1): 101-106.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4081/53
Vancouver
Ferrarotto R, Schetino G, Freitas D, Capelozzi V, Hoff PM. Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature [Internet]. Oncology Reviews. 2010 ; 4( 1): 101-106.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4081/53
Artigo de periodico
Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow (2008)
Abreu, A. P. S.; Milani, C.; Katayama, M. L. H.; Barbosa, K. C.; Fonseca, L. Gomes da; Goes, J. C. S.; Brentani, M. M.; Folgueira, M. A. A. Koike
Source: International Journal of Biological Markers. Unidade: FM
Subjects: POLIMORFISMO, EXPRESSÃO GÊNICA, ASTRÓCITOS (ESTUDO CLÍNICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABREU, A. P. S. et al. Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow. International Journal of Biological Markers, v. 23, n. 4, p. 219-224, 2008Tradução . . Disponível em: https://doi.org/10.5301/jbm.2009.1354. Acesso em: 13 nov. 2024.
APA
Abreu, A. P. S., Milani, C., Katayama, M. L. H., Barbosa, K. C., Fonseca, L. G. da, Goes, J. C. S., et al. (2008). Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow. International Journal of Biological Markers, 23( 4), 219-224. doi:10.5301/jbm.2009.1354
NLM
Abreu APS, Milani C, Katayama MLH, Barbosa KC, Fonseca LG da, Goes JCS, Brentani MM, Folgueira MAAK. Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow [Internet]. International Journal of Biological Markers. 2008 ; 23( 4): 219-224.[citado 2024 nov. 13 ] Available from: https://doi.org/10.5301/jbm.2009.1354
Vancouver
Abreu APS, Milani C, Katayama MLH, Barbosa KC, Fonseca LG da, Goes JCS, Brentani MM, Folgueira MAAK. Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow [Internet]. International Journal of Biological Markers. 2008 ; 23( 4): 219-224.[citado 2024 nov. 13 ] Available from: https://doi.org/10.5301/jbm.2009.1354
Artigo de periodico
Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine (2008)
Conde, S. J.; Luvizotto, R. A.; Síbio, M. T.; Katayama, M. L. H.; Brentani, M. M.; Nogueira, C. R.
Source: Journal of Endocrinological Investigation. Unidade: FM
Subjects: SEGUIMENTOS, EXPRESSÃO GÊNICA, NEOPLASIAS MAMÁRIAS (GENÉTICA), CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONDE, S. J. et al. Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine. Journal of Endocrinological Investigation, v. 31, n. 12, p. 1047-1051, 2008Tradução . . Disponível em: https://doi.org/10.1007/bf03345650. Acesso em: 13 nov. 2024.
APA
Conde, S. J., Luvizotto, R. A., Síbio, M. T., Katayama, M. L. H., Brentani, M. M., & Nogueira, C. R. (2008). Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine. Journal of Endocrinological Investigation, 31( 12), 1047-1051. doi:10.1007/bf03345650
NLM
Conde SJ, Luvizotto RA, Síbio MT, Katayama MLH, Brentani MM, Nogueira CR. Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine [Internet]. Journal of Endocrinological Investigation. 2008 ; 31( 12): 1047-1051.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/bf03345650
Vancouver
Conde SJ, Luvizotto RA, Síbio MT, Katayama MLH, Brentani MM, Nogueira CR. Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine [Internet]. Journal of Endocrinological Investigation. 2008 ; 31( 12): 1047-1051.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/bf03345650
Artigo de periodico
Distribution of lymph nodes in the mesorectum: how deep is TME necessary? (2008)
Perez, R. O.; Seid, V. E.; Bresciani, E. H.; Bresciani, Cláudio José Caldas; Proscurshim, I.; Pereira, D. D.; Kruglensky, D.; Rawet, Viviane; Habr Gama, Angelita; Kiss, D.
Source: Tecniques in coloproctology. Unidade: FM
Subjects: GÂNGLIOS LINFÁTICOS (PATOLOGIA), NEOPLASIAS RETAIS, DISSECÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, R. O. et al. Distribution of lymph nodes in the mesorectum: how deep is TME necessary?. Tecniques in coloproctology, v. 12, n. 1, p. 39-43, 2008Tradução . . Disponível em: https://doi.org/10.1007/s10151-008-0396-8. Acesso em: 13 nov. 2024.
APA
Perez, R. O., Seid, V. E., Bresciani, E. H., Bresciani, C. J. C., Proscurshim, I., Pereira, D. D., et al. (2008). Distribution of lymph nodes in the mesorectum: how deep is TME necessary? Tecniques in coloproctology, 12( 1), 39-43. doi:10.1007/s10151-008-0396-8
NLM
Perez RO, Seid VE, Bresciani EH, Bresciani CJC, Proscurshim I, Pereira DD, Kruglensky D, Rawet V, Habr Gama A, Kiss D. Distribution of lymph nodes in the mesorectum: how deep is TME necessary? [Internet]. Tecniques in coloproctology. 2008 ;12( 1): 39-43.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10151-008-0396-8
Vancouver
Perez RO, Seid VE, Bresciani EH, Bresciani CJC, Proscurshim I, Pereira DD, Kruglensky D, Rawet V, Habr Gama A, Kiss D. Distribution of lymph nodes in the mesorectum: how deep is TME necessary? [Internet]. Tecniques in coloproctology. 2008 ;12( 1): 39-43.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10151-008-0396-8
Artigo de periodico
Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjunvant chemoradiation (2008)
Habr Gama, Angelita; Gama Rodrigues, Joaquim José; Perez, R. O.; Proscurshim, I.; Julião, G. P. São; Kruglensky, D.; Kiss, D.; Cecconnelllo, Ivan; Buchpiguel, Carlos Alberto
Source: Tecniques in coloproctology. Unidade: FM
Subjects: NEOPLASIAS RETAIS (QUIMIOTERAPIA), IMUNOSSUPRESSÃO, SEGUIMENTOS, QUIMIOTERAPIA ADJUVANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HABR GAMA, Angelita et al. Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjunvant chemoradiation. Tecniques in coloproctology, v. 12, n. 1, p. 73-78, 2008Tradução . . Disponível em: http://www.springerlink.com/content/a25247p237388x77/fulltext.pdf. Acesso em: 13 nov. 2024.
APA
Habr Gama, A., Gama Rodrigues, J. J., Perez, R. O., Proscurshim, I., Julião, G. P. S., Kruglensky, D., et al. (2008). Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjunvant chemoradiation. Tecniques in coloproctology, 12( 1), 73-78. Recuperado de http://www.springerlink.com/content/a25247p237388x77/fulltext.pdf
NLM
Habr Gama A, Gama Rodrigues JJ, Perez RO, Proscurshim I, Julião GPS, Kruglensky D, Kiss D, Cecconnelllo I, Buchpiguel CA. Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjunvant chemoradiation [Internet]. Tecniques in coloproctology. 2008 ;12( 1): 73-78.[citado 2024 nov. 13 ] Available from: http://www.springerlink.com/content/a25247p237388x77/fulltext.pdf
Vancouver
Habr Gama A, Gama Rodrigues JJ, Perez RO, Proscurshim I, Julião GPS, Kruglensky D, Kiss D, Cecconnelllo I, Buchpiguel CA. Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjunvant chemoradiation [Internet]. Tecniques in coloproctology. 2008 ;12( 1): 73-78.[citado 2024 nov. 13 ] Available from: http://www.springerlink.com/content/a25247p237388x77/fulltext.pdf
Trabalho de evento-resumo
Differential gene expression profile of carcinoma associated fibroblasts as compared to those derived from normal breast tissue (2007)
Rozenchan, P. B.; Katayama, M. L. H.; Fernandes, P. C.; Lyra, F. C.; Folgueira, M. A. A. K.; Góes, J. C. S. G.; Santos, M. F.; Brentani, M. M.
Source: Abstracts. Conference titles: International Conference on Tumor Microenvironment: Progression, Therapy and Prevention. Unidade: FM
Subjects: CARCINOMA, FIBROBLASTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROZENCHAN, P. B. et al. Differential gene expression profile of carcinoma associated fibroblasts as compared to those derived from normal breast tissue. 2007, Anais.. Florence: Faculdade de Medicina, Universidade de São Paulo, 2007. p. 166. . Acesso em: 13 nov. 2024.
APA
Rozenchan, P. B., Katayama, M. L. H., Fernandes, P. C., Lyra, F. C., Folgueira, M. A. A. K., Góes, J. C. S. G., et al. (2007). Differential gene expression profile of carcinoma associated fibroblasts as compared to those derived from normal breast tissue. In Abstracts (p. 166). Florence: Faculdade de Medicina, Universidade de São Paulo.
NLM
Rozenchan PB, Katayama MLH, Fernandes PC, Lyra FC, Folgueira MAAK, Góes JCSG, Santos MF, Brentani MM. Differential gene expression profile of carcinoma associated fibroblasts as compared to those derived from normal breast tissue. Abstracts. 2007 ; 166.[citado 2024 nov. 13 ]
Vancouver
Rozenchan PB, Katayama MLH, Fernandes PC, Lyra FC, Folgueira MAAK, Góes JCSG, Santos MF, Brentani MM. Differential gene expression profile of carcinoma associated fibroblasts as compared to those derived from normal breast tissue. Abstracts. 2007 ; 166.[citado 2024 nov. 13 ]
Trabalho de evento
Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy (2007)
Andrade, L. N. S.; Pinheiro, M. C.; Nonogaki, S.; Nantel, F.; Battistini, B.; Sirois, P.; Chammas, R.
Source: Abstracts. Conference titles: International Conference on Tumor Microenvironment: Progression, Therapy and Prevention. Unidade: FM
Subjects: INFLAMAÇÃO, EXPRESSÃO GÊNICA, MELANOMA, TERAPIAS COMPLEMENTARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, L. N. S. et al. Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy. 2007, Anais.. Florence: Faculdade de Medicina, Universidade de São Paulo, 2007. p. 47-51. . Acesso em: 13 nov. 2024.
APA
Andrade, L. N. S., Pinheiro, M. C., Nonogaki, S., Nantel, F., Battistini, B., Sirois, P., & Chammas, R. (2007). Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy. In Abstracts (p. 47-51). Florence: Faculdade de Medicina, Universidade de São Paulo.
NLM
Andrade LNS, Pinheiro MC, Nonogaki S, Nantel F, Battistini B, Sirois P, Chammas R. Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy. Abstracts. 2007 ; 47-51.[citado 2024 nov. 13 ]
Vancouver
Andrade LNS, Pinheiro MC, Nonogaki S, Nantel F, Battistini B, Sirois P, Chammas R. Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy. Abstracts. 2007 ; 47-51.[citado 2024 nov. 13 ]
Trabalho de evento-resumo
The BKB1 receptor antagonist R715 increases melanoma vascular permeability leading to improved sensitivity to the chemotherapeutic agent dacarbazine (2007)
Andrade, L. N. S.; Pinheiro, M. C.; Nonogaki, S.; Nantel, F.; Battistini, B.; Sirois, P.; Chammas, Roger
Source: Resumos. Conference titles: International conference on tumor microenvironment. Unidade: FM
Subjects: ANTINEOPLÁSICOS, MELANOMA, INIBIDORES DE CRESCIMENTO, INIBIDORES QUÍMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, L. N. S. et al. The BKB1 receptor antagonist R715 increases melanoma vascular permeability leading to improved sensitivity to the chemotherapeutic agent dacarbazine. 2007, Anais.. Bologna, Italia: Faculdade de Medicina, Universidade de São Paulo, 2007. . Acesso em: 13 nov. 2024.
APA
Andrade, L. N. S., Pinheiro, M. C., Nonogaki, S., Nantel, F., Battistini, B., Sirois, P., & Chammas, R. (2007). The BKB1 receptor antagonist R715 increases melanoma vascular permeability leading to improved sensitivity to the chemotherapeutic agent dacarbazine. In Resumos. Bologna, Italia: Faculdade de Medicina, Universidade de São Paulo.
NLM
Andrade LNS, Pinheiro MC, Nonogaki S, Nantel F, Battistini B, Sirois P, Chammas R. The BKB1 receptor antagonist R715 increases melanoma vascular permeability leading to improved sensitivity to the chemotherapeutic agent dacarbazine. Resumos. 2007 ;[citado 2024 nov. 13 ]
Vancouver
Andrade LNS, Pinheiro MC, Nonogaki S, Nantel F, Battistini B, Sirois P, Chammas R. The BKB1 receptor antagonist R715 increases melanoma vascular permeability leading to improved sensitivity to the chemotherapeutic agent dacarbazine. Resumos. 2007 ;[citado 2024 nov. 13 ]
Artigo de periodico
Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin (2007)
Rubio, I. G. S.; Silva, M. N. C.; Knobel, M.; Romão, R.; Possato, R.; Gebrin, E. M. M. S.; Buchpiguel, C.; Medeiros-Neto, G.
Source: Journal of Endocrinological Investigation. Unidade: FM
Subjects: SEGUIMENTOS, FLUXO SANGUÍNEO REGIONAL, PERÍODO PÓS-OPERATÓRIO, RNA, TIROTROFINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUBIO, I. G. S. et al. Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin. Journal of Endocrinological Investigation, v. 30, n. 7, p. 535-540, 2007Tradução . . Disponível em: https://doi.org/10.1007/bf03346345. Acesso em: 13 nov. 2024.
APA
Rubio, I. G. S., Silva, M. N. C., Knobel, M., Romão, R., Possato, R., Gebrin, E. M. M. S., et al. (2007). Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin. Journal of Endocrinological Investigation, 30( 7), 535-540. doi:10.1007/bf03346345
NLM
Rubio IGS, Silva MNC, Knobel M, Romão R, Possato R, Gebrin EMMS, Buchpiguel C, Medeiros-Neto G. Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin [Internet]. Journal of Endocrinological Investigation. 2007 ; 30( 7): 535-540.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/bf03346345
Vancouver
Rubio IGS, Silva MNC, Knobel M, Romão R, Possato R, Gebrin EMMS, Buchpiguel C, Medeiros-Neto G. Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin [Internet]. Journal of Endocrinological Investigation. 2007 ; 30( 7): 535-540.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/bf03346345

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Indexado em